Cost Comparison of LHRH Analogues and Orchidectomy for Prostate Cancer
Author Information
Author(s): L.E. Rutqvist, N. Wilking
Primary Institution: Radiumhemmet, Karolinska Hospital
Hypothesis
Is the cost of LHRH analogues lower than that of surgical orchidectomy for treating advanced prostate cancer?
Conclusion
Initial treatment with LHRH analogues followed by deferred orchidectomy is more cost-effective than immediate orchidectomy.
Supporting Evidence
- The average cost for orchidectomy was estimated at ?2,580, which is 7-31% less than for LHRH analogue treatment.
- Initial LHRH analogue treatment followed by deferred orchidectomy could reduce costs by about 26%.
- 85% of patients could avoid surgery with the combined treatment approach.
Takeaway
This study looked at how much it costs to treat prostate cancer with two methods: surgery and medication. It found that using medication first can save money.
Methodology
Cost estimates were based on hospital stay data and treatment times from clinical trials.
Potential Biases
Potential underestimation of costs due to reliance on average daily costs and hospital stay durations.
Limitations
The study did not include costs for clinical follow-up and diagnostic examinations, which may affect the overall cost comparison.
Participant Demographics
Most patients were elderly, with an average age of 74 years.
Want to read the original?
Access the complete publication on the publisher's website